EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Applications of Carbon Dots and Graphene Quantum Dots in Treatment of Diabetes

Sho Nakayama iD, Eric J Shepard iD, Abhinandan Banerjee iD, Xiaoda Yang iD, Debbie C Crans iD

Molecules · 11.03.2026 · 31 (6) · 941

DOI: 10.3390/molecules31060941 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 11.03.2026. Verfasst von Sho Nakayama und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Colorado State University, Fort Collins, CO 80523, USA. Hauptthemen laut MEDLINE: Carbon Quantum Dots, Graphite, Hypoglycemic Agents, Diabetes Mellitus. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 170 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Carbon nanoparticles (CNPs) are increasingly being considered for medical applications. The objective of this article is to determine which anti-diabetic drugs and compounds have been enhanced by CNPs, and which CNP scaffolds were found to be successful. The anti-diabetic drugs administered loaded on CNPs include insulin, metformin, glimepiride and vanadium compounds. Carbon quantum dots (CQDs), graphene quantum dots (GQDs), graphene oxide quantum dots (GOQDs), hybrid systems and fullerenes are all carriers able to alleviate symptoms of diabetes. Successful CNPs are 10 nm or less and can have a flat pancake structure, as well as the spherical CQDs and the spherical-but-hollow gadofullerene (Gd-C82). The use of the carbon nanoparticle scaffold includes oral, intravenous administration and placement as an implant in a diabetic animal model system. In vitro studies in an insulin-resistant model demonstrate a 500–1000-fold enhancement of metformin when placed on the pegylated GOQD. Although some CNPs have low toxicity, more information is needed for understanding the metabolism associated with uptake and processing. In summary, CNPs represent a novel class of nanoparticles that has promising potential. They enhance the efficacy of anti-diabetic drugs, have low toxicity, and keep the loaded drug protected until reaching their targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carbon Quantum DotsGraphiteHypoglycemic AgentsDiabetes MellitusQuantum DotsAnimalsHumansMetforminDrug CarriersCarbon

Stichwörter der Autor:innen

Diabetesanimal studiesblood glucosecarbon dotscarbon nanoparticlescarbon quantum dotsdrug delivery systemglimepiridegraphene quantum dotsin vitroin vivoinsulinmetforminvanadium antidiabetic agents

Substanzen

GraphiteHypoglycemic AgentsMetforminDrug CarriersCarbon

Autor:innen und Institutionen

  • Department of Chemistry, Colorado State University, Fort Collins, CO 80523, USA.
  • State Key Laboratories of Natural and Mimetic Drugs and Department of Chemical Biology, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.
  • Cell and Molecular Biology Program, Colorado State University, Fort Collins, CO 80523, USA.

ORCID-Profile: Sho Nakayama, Eric J Shepard, Abhinandan Banerjee, Xiaoda Yang, Debbie C Crans

Zitieren

APA

Nakayama, S., Shepard, E. J., Banerjee, A., Yang, X., & Crans, D. C. (2026). Applications of Carbon Dots and Graphene Quantum Dots in Treatment of Diabetes. Molecules, 31(6), 941. https://doi.org/10.3390/molecules31060941

Vancouver

Nakayama S, Shepard EJ, Banerjee A, Yang X, Crans DC. Applications of Carbon Dots and Graphene Quantum Dots in Treatment of Diabetes. Molecules. 2026;31(6):941. doi:10.3390/molecules31060941

BibTeX
@article{Nakayama2026,
  author = {Nakayama, Sho and Shepard, Eric J and Banerjee, Abhinandan and Yang, Xiaoda and Crans, Debbie C},
  title = {Applications of Carbon Dots and Graphene Quantum Dots in Treatment of Diabetes},
  journal = {Molecules},
  year = {2026},
  volume = {31},
  number = {6},
  pages = {941},
  doi = {10.3390/molecules31060941}
}
Kostenlos starten →